Optimal Regimens and Cutoff Evaluation of Tildipirosin Against Pasteurella multocida

• Váldodahkkit: Zhixin Lei (Dahkki), Qianying Liu (Dahkki), Yi Qi (Dahkki), Bing Yang (Dahkki), Haseeb Khaliq (Dahkki), Jincheng Xiong (Dahkki), Gopi Krishna Moku (Dahkki), Saeed Ahmed (Dahkki), Kun Li (Dahkki), Hui Zhang (Dahkki), Wenqiu Zhang (Dahkki), Jiyue Cao (Dahkki), Qigai He (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2018-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Pasteurella multocida (PM) can invade the upper respiratory tract of the body and cause death and high morbidity. Tildipirosin, a new 16-membered-ring macrolide antimicrobial, has been recommended for the treatment of respiratory diseases. The objective of this research was to improve the dose regim...